Molecular subtyping drives confident treatment decisions for breast cancer
Human Breast Cancer Molecular Subtyping Quantitative Detection Kit(PCR-Fluorophore-labeling Probes)
China NMPA certified | CE Certified
Non-invasive, Instant, Home-based and Self-testing
Prediction and Screening of Pre-eclampsia in the 2nd and 3rd Trimester of Prenancy.
China NMPA certified | CE Certified
Latest News
The results from a prospective clinical study on CercaTest RED™ was presented in the Asia Pacific Congress in Maternal Fetal Medicine 2025 (APCMFM) held from November 1 to 3 in Osaka, Japan. The Asia-Pacific Congress of Maternal-Fetal Medicine (APCMFM) is one of the most influential academic […]
BERLIN, GERMANY, October 27, 2025 — Cerca Biotech., a German-based diagnostics company, announces the publication of a white paper highlighting the importance of molecular diagnostics in HER2-low breast cancer cases as a potential to improve the diagnostic complexity. MammaTyper® is a molecular diagnostic test from Cerca Biotech, a reverse transcription, […]
During the 2025 International Forum on Gonococcal Infections and Resistance (IFGIR) from October 17 to 19 in Hangzhou, China, Shuwen Biotech presented its vision and technological breakthroughs in gonococcal drug resistance detection, offering a solution for global antimicrobial resistance (AMR) response. As a leading academic forum […]
Screening, diagnosis & precision medicine for women’s health.
We are committed to becoming a global leader in innovative diagnosis and precision medicine focused on women’s health.
Precision Medicine for Breast Cancer
Precision Medicine for Oncology
Maternal Fetal Diagnostics & Health
Reproductive Tract Infection & Health